Click here
Physician Portal
Advancing the Understanding of Emerging Therapies Through Observational Research & Global Collaboration
Healing Hope International is a 501(c)(3) nonprofit research and education organization focused on advancing the understanding of emerging therapies through real-world evidence and global clinical collaboration.
We support the ethical collection and analysis of observational data across international care settings to better characterize safety, outcomes, and patient-reported experiences associated with innovative therapeutic approaches.
Our work contributes to bridging scientific research, clinical practice, and patient reported outcomes by supporting transparent, data driven research in areas where treatment options remain limited.
We collaborate with patients, clinicians, and researchers to support observational studies, global research initiatives, and responsible data collection aligned with applicable ethical and regulatory standards.
Healing Hope International does not provide medical treatment, direct clinical care, or determine patient eligibility for therapies.
All treatment decisions are made independently between patients and their licensed healthcare providers.
Clinical Research
Educational Resource
Clinical Research: Educational Overview
Healing Hope International is an educational resource that provides publicly available information about observational research, research methods, and real world evidence related to emerging therapies.
Our materials focus on research education and the ethical collection and analysis of observational data across international care settings.
We provide publicly available research information about observational studies and related educational topics, without offering clinical direction, therapy access services, or patient participation coordination.

Healing Hope International provides publicly available educational materials and research information only. For clinicians and researchers, our role is limited to research education and observational data — not clinical coordination or therapy access facilitation.
We do not provide expanded access processes, compassionate use applications, or investigational therapy access services.
Healing Hope International is an educational resource only. Individuals seeking information about investigational therapies must work directly with their licensed physician and the therapy's sponsor.
Observational studies associated with our initiatives are conducted in accordance with applicable ethical guidelines and may be reviewed by Institutional Review Boards (IRBs) when required.
Participation in observational research does not provide access to treatment. All medical decisions are made independently between patients and their licensed healthcare providers.
Clinical Research
Observational Studies
Observational Research Studies Registry
Healing Hope International facilitates a registry of observational research studies focusing on emerging therapies and real-world outcomes. This registry provides a transparent overview of ongoing and completed studies, aligning with our commitment to advancing scientific understanding through ethical data collection.
All listed studies are observational in nature. Healing Hope International does not provide medical treatment or assign interventions. Participation in observational research does not provide access to therapy. All treatment decisions are made independently between patients and their licensed healthcare providers.
Our Mission: Accelerating Access to Life-Saving Therapies
As a 501(c)(3) charitable organization, we are committed to making a meaningful difference in patients' lives through innovative approaches to treatment access.
Scientific Breakthroughs
Identify cutting-edge therapies with potential to save lives and improve quality of life.
Regulatory Navigation
Guide treatments through complex approval pathways and compassionate use requests.
Patient Access
Ensure life-changing therapies reach those with urgent medical needs when standard options fail.
Data Collection
Collect observational data from international research to improve treatment efficacy and inform future innovations.
Our Approach
Research & Regulatory
Our Approach: Research & Regulatory Awareness
Healing Hope International employs a multi-faceted approach to advance understanding of emerging therapies. We combine global expertise with rigorous research and regulatory vigilance.
Global Expertise
Leveraging knowledge of international research environments and regulatory frameworks across diverse regions for comprehensive therapy evaluation.
Research Collaboration
Partnering with clinicians, researchers, and institutions to support ethical observational studies and real-world data collection.
Regulatory Awareness
Continuously reviewing public regulatory guidance in key markets (US, Europe, global) to understand evolving research landscapes.
Observational Research Data
Collecting and analyzing real-world observational data from international settings to inform patient outcomes, safety, and treatment experiences.
Scientific Insight
Generating data-driven insights through structured observational research to contribute to a broader understanding of emerging therapeutic approaches.
Nonprofit Mission
Operating as a tax-exempt organization dedicated to advancing research, education, and transparency in emerging therapies through real-world evidence.
Educational Overview
Compassionate Use: Understanding Expanded Access Pathways

Healing Hope International does not facilitate, coordinate, or assist with expanded access or compassionate use processes. All expanded access requests must be initiated and managed exclusively by the patient's licensed physician and the therapy's sponsor, in accordance with applicable regulatory requirements.
Patient Considerations (Educational Overview)
Expanded access, also known as compassionate use, is a regulatory pathway that may be considered by licensed physicians for patients with serious or life-threatening conditions when no comparable alternatives are available. Healing Hope International provides general educational information to help patients and families understand when these pathways may be discussed with their healthcare providers.
Regulatory Process Awareness
Expanded access requests are initiated, prepared, and managed exclusively by licensed physicians in coordination with therapy sponsors and the relevant regulatory authorities. Healing Hope International does not prepare, submit, or manage regulatory applications of any kind. We may provide general educational resources regarding publicly available regulatory frameworks only.
Care Coordination Is Independent of Our Organization
All treatment-related coordination — including communication with manufacturers, regulatory authorities, and care teams — is conducted independently by the treating physician and relevant stakeholders. Healing Hope International does not coordinate treatment delivery, manage therapy access, or act as an intermediary between patients and therapy sponsors.
Observational Data & Research
Healing Hope International supports the collection of real-world observational data from patients who independently pursue treatment, where ethically appropriate and consented. This research focuses on understanding safety, patient experiences, and outcomes to contribute to broader scientific knowledge — not to facilitate or guide access to therapies.
Research & Education Mission
Our work is focused exclusively on advancing understanding through observational research and education. We help improve transparency and public awareness of emerging therapies and regulatory pathways. We do not provide medical advice, treatment recommendations, or assistance with accessing investigational therapies.
Global Market Access Programs
Multinational Projects
Operating pilot programs spanning North America, Europe, Asia, and Africa to establish access models that work across borders. As a 501(c)(3) charitable organization, we can partner directly with governments and NGOs without profit constraints.
Clinical Development
Coordinating cross-border clinical trials and data sharing for orphan drugs and breakthrough therapies with limited market incentives. We also collect observational data of international research to identify patterns and optimize treatment protocols across diverse populations. Our 501(c)(3) status enables us to channel 100% of funding into research and patient support.
Ethical Approvals
Working directly with local regulatory bodies to ensure ethical, timely review and approval processes that respect cultural contexts. Our charitable organization structure promotes transparency and accountability in all approval processes.
Get Involved: Support Our Mission
Volunteer Your Expertise
We welcome regulatory specialists, medical writers, patient navigators, and translators to join our global network of dedicated volunteers making access possible.
Donate to Fund Access
Your contributions directly support urgent compassionate use applications, educational resources, and advocacy campaigns for policy reform. As a 501(c)(3) charitable organization, all donations are tax-deductible to the fullest extent allowed by law.
Become a Partner
Corporate sponsors, foundations, and healthcare organizations can amplify our impact through financial support, expertise sharing, and collaborative programs.
Contribute to Research
We also collect observational data of international research to improve treatment access pathways. Your participation helps build a comprehensive database that informs future policy and practice in compassionate use programs.
Founder | CEO
Meet Our Founder | CEO
Dr. Jonatha Leicher
Board certified Adult Gerontology Acute Care Nurse Practitioner with over a decade of experience in emergency, trauma, cardiovascular, and critical care across leading health systems. She holds a Doctor of Nursing Practice from the University of Arizona, with advanced training from Harvard, Stanford, and Mayo Clinic, and certifications in critical care, neuro-assessment, and regulatory trial management. Dr. Leicher specializes in complex cardiopulmonary, renal, and neurologic cases, integrating conventional and evidence-based complementary therapies.
Leadership & Core Pillars
Visionary Strategic Leadership
As Chief Executive Officer, Dr. Leicher provides clear, forward-thinking leadership that guides Healing Hope International's mission and long-term strategy. She ensures that all initiatives are purpose-driven and aligned with the organization's commitment to compassionate healing and global patient empowerment.
Global Patient Advocacy
Dr. Leicher leads international patient advocacy efforts, including compassionate use programs, with a steadfast commitment to dignity, respect, and equitable access to care. Her work centers on ensuring that patients and families are heard, supported, and meaningfully represented throughout their healing journey.
Ethical Integrity & Responsible Communication
Integrity is foundational to Dr. Leicher's leadership. She upholds the highest ethical standards in governance, clinical collaboration, and public communication—particularly in the responsible discussion of emerging medical therapies—fostering trust, transparency, and accountability at every level of the organization.
Global Partnership Development & Collaboration
Through strategic collaboration, Dr. Leicher builds strong partnerships with clinicians, researchers, international treatment centers, and mission-aligned organizations. These alliances expand access to innovative, life-changing therapies and strengthen Healing Hope International's global impact.
Sustainable Organizational Growth & Community Engagement
Dr. Leicher leads intentional, sustainable organizational growth while nurturing a vibrant global community. She cultivates environments that support healing, education, and collaboration, ensuring that the organization's values are reflected across all programs, partnerships, and outreach initiatives.
Regulatory Leadership
Meet Our Regulatory Affairs Director:
Tamara Tamas
Tamara bridges cutting edge cellular therapies with patient care as our regulatory strategist and biochemist. With over 15 years of experience in research, she is advancing into complex regulatory frameworks to create viable pathways for innovative treatments to reach patients in need.
Scientific Foundation
MS in Biopharmaceutical Regulatory Affairs and Chemistry degree with biochemistry focus. Her specialized training enables her to understand the molecular mechanisms of cellular therapies while developing regulatory strategies that satisfy scientific and safety requirements across multiple jurisdictions.
Manufacturing Expertise
Specialized in cGMP-compliant cell therapy production and cleanroom operations. Tamara has implemented quality management systems for cellular manufacturing facilities in three countries and trains teams on maintaining regulatory compliance throughout the production process.
Global Access
Coordinates international therapy delivery through compassionate use frameworks. She has successfully facilitated treatment access for over 200 patients across 14 countries through expanded access programs, physician coordination, and hospital exemptions.
Tamara's comprehensive approach integrates regulatory strategy with practical implementation, ensuring that promising therapies can overcome administrative barriers to reach patients with urgent medical needs. Her work includes developing regulatory documentation, navigating Ethics Committee approvals, and creating patient specific access plans for complex cases.
As a recognized expert in her field, Tamara regularly consults with regulatory agencies and contributes to policy discussions about improving access pathways for experimental treatments. Her patient centered philosophy drives her commitment to finding creative solutions within existing regulatory frameworks.
Founded by Tamara C Tamas, Biochemist & Clinical Research Professional
ORCID: https://orcid.org/0000-0001-8213-6953
Our Vision for the Future
1000+
Patients Helped
Our goal is to connect over a thousand patients with life-saving therapies through compassionate use by 2030.
25+
Global Reach
Expanding our network to cover more than 25 countries and all major therapeutic areas requiring urgent access.
100%
Research Impact
We collect observational data from international research to improve treatment outcomes and drive policy reforms for more equitable, accelerated patient access to innovative treatments worldwide.
Healing Hope International
Make a Difference: Donate Today
Your generosity directly fuels our mission to accelerate access to life saving therapies. Every contribution supports urgent compassionate use applications, vital educational resources, and impactful advocacy campaigns for policy reform.
As a recognized 501(c)(3) charitable organization, all donations to Healing Hope International are tax-deductible to the fullest extent allowed by law. Help us bring hope and healing to those in critical need.
Help fund immediate access to life-saving therapies — support a child's treatment today.
$25
Supports patient outreach and awareness
$50
Funds advocacy work and policy reform
$100
Contributes directly to treatment access for a patient in need
Monthly Giving
Become a monthly donor — even $10/month adds up to life-changing impact. Recurring gifts allow us to plan ahead and respond faster to urgent patient needs.
Connect with Healing Hope International
Healing Hope International invites patients, families, clinicians, researchers, and missionaligned partners to join in advancing compassionate, ethical, and patientcentered care worldwide. Together, we can expand access to healing, empower informed choice, and transform hope into meaningful outcomes for individuals and communities across the globe.
Stay informed about our mission, patient success stories, and advocacy for life-saving therapies. Join our growing community and help us make a global impact through collaboration and awareness.
Healing Hope International is a research and education organization. We do not provide medical advice, treatment, or guarantee access to therapies. Many therapies referenced may be investigational and not approved for specific indications. These therapies may carry unknown risks, and outcomes are not guaranteed. Participation in observational research does not provide access to treatment.
All medical decisions should be made in consultation with a licensed healthcare provider.